| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/18/2000 | US6090564 Amino acid sequence of human small nuclear ribonucleoprotein protein; for diagnosis, prevention and treatment of systemic lupus erythematosus |
| 07/18/2000 | US6090563 Growth differentiation factor-6 |
| 07/18/2000 | US6090387 Vaccination and methods against diseases resulting from pathogenic responses |
| 07/18/2000 | US6090383 Monoclonal antibodies to transforming growth factor-β and methods of use |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/18/2000 | US6090381 Stimulation of an immune response with antibodies labeled with the . .alpha-galactosyl epitope |
| 07/18/2000 | US6090380 Treatment of rheumatoid arthritis by oral administration of pooled human immunoglobulin |
| 07/18/2000 | US6090365 Radioimmunotherapy of lymphoma using anti-CD20 antibodies |
| 07/18/2000 | CA2162689C Immunotoxins comprising gelonin and an antibody |
| 07/18/2000 | CA2093927C Ligand-mediated immunofunctional hormone binding protein assay method |
| 07/18/2000 | CA1341055C Transfectant cell lines which express the major human rhinovirus receptor |
| 07/18/2000 | CA1341053C Polypeptide and protein derivatives and process for their preparation |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |
| 07/13/2000 | WO2000040729A1 Streptococcal abc transporter protein |
| 07/13/2000 | WO2000040722A2 Insulin-synthesis genes |
| 07/13/2000 | WO2000040721A1 Monocyte-derived nucleic acids and related compositions and methods |
| 07/13/2000 | WO2000040719A2 Tissue repair protein involved in orofacial clefting and uses thereof |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040713A1 Method of preventing immune and hypersensitivity reactions |
| 07/13/2000 | WO2000040698A1 Pth receptor and screening assay utilizing the same |
| 07/13/2000 | WO2000040616A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
| 07/13/2000 | WO2000040615A2 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
| 07/13/2000 | WO2000040614A2 Characterization of the soc/crac calcium channel protein family |
| 07/13/2000 | WO2000040607A2 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor |
| 07/13/2000 | WO2000040597A1 Method and composition for angiogenesis inhibition |
| 07/13/2000 | WO2000040263A1 Production and use of a composition containing ivig for treating diseases that are characterized by elevated extracellular fasl titers |
| 07/13/2000 | WO2000040262A1 Novel agents and methods for treatment and diagnosis of ocular disorders |
| 07/13/2000 | WO2000040201A2 Method and means for reducing chemotherapeutic drug resistance in-situ within neoplasms of epithelial cell origin |
| 07/13/2000 | WO2000040089A1 Targeted transscleral controlled release drug delivery to the retina and choroid |
| 07/13/2000 | WO2000024897B1 Cell surface molecule-induced macrophage activation |
| 07/13/2000 | WO2000022121A3 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 07/13/2000 | WO2000021986A3 Matrix-remodeling genes |
| 07/13/2000 | WO2000018801A3 Ncam binding compounds |
| 07/13/2000 | WO2000018351A3 Aglyco products and methods of use |
| 07/13/2000 | WO2000017646A9 DIAGNOSTIC ASSAYS FOR DETECTION OF $i(ENTAMOEBA HISTOLYTICA) |
| 07/13/2000 | WO2000015175A3 Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells |
| 07/13/2000 | WO2000007545A9 Apoptosis proteins |
| 07/13/2000 | WO1999061579A3 MarA FAMILY HELIX-TURN-HELIX DOMAINS AND THEIR METHODS OF USE |
| 07/13/2000 | WO1997020575A8 Targeted adenovirus vectors |
| 07/13/2000 | DE19900635A1 Selektion von monoklonalen Antikörpern Selection of monoclonal antibodies |
| 07/13/2000 | DE19900503A1 Verwendung einer Zusammensetzung zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen mit erhöhten extrazellulären FasL-Titern, Verfahren zur prophylaktischen Eignungs- bzw. Qualitätskontrolle derselben, Verfahren zur Herstellung von Arzneimitteln zur Behandlung obiger Krankheiten mit gesteigerter Wirksamkeit Use of a composition for the manufacture of a medicament for the treatment of diseases with increased extracellular FasL titers method for the prophylactic or suitability quality control thereof, a process for the preparation of medicaments for the treatment of the above diseases with enhanced efficacy |
| 07/13/2000 | CA2753331A1 Soluble receptor br43x2 and methods of using |
| 07/13/2000 | CA2363839A1 Wound healing and orofacial clefting |
| 07/13/2000 | CA2360396A1 Characterization of a calcium channel family |
| 07/13/2000 | CA2359892A1 Methods of eliciting broadly neutralizing antibodies targeting hiv-1 gp41 |
| 07/13/2000 | CA2358562A1 Monocyte-derived nucleic acids and related compositions and methods |
| 07/13/2000 | CA2358296A1 Targeted transscleral controlled release drug delivery to the retina and choroid |
| 07/13/2000 | CA2357996A1 Streptococcal abc transporter protein |
| 07/13/2000 | CA2357677A1 Insulin-synthesis genes |
| 07/13/2000 | CA2357146A1 Human cyclic nucleotide pdes |
| 07/13/2000 | CA2356401A1 Expression and export of anti-obesity proteins as fc fusion proteins |
| 07/12/2000 | EP1018552A1 Production of pluripotent granulocyte colony-stimulating factor |
| 07/12/2000 | EP1018518A2 Use of autoantibodies for tumor therapy and prophylaxis |
| 07/12/2000 | EP1018517A2 Binding agents to CD23 for treatment of inflammatory, autoimmune or allergic diseases |
| 07/12/2000 | EP1018009A1 Homogeneous method for detecting and/or determining phosphorylating activity in a biological material |
| 07/12/2000 | EP1017828A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 07/12/2000 | EP1017827A1 New human cathepsin |
| 07/12/2000 | EP1017826A2 Compositions and methods for identifying pkb kinase inhibitors |
| 07/12/2000 | EP1017818A2 Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof |
| 07/12/2000 | EP1017816A1 Insulin-like polypeptide and uses therefor |
| 07/12/2000 | EP1017815A1 Murine model for human carcinoma |
| 07/12/2000 | EP1017813A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/12/2000 | EP1017811A1 G-protein coupled glycoprotein hormone receptor hg38 |
| 07/12/2000 | EP1017810A1 Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 07/12/2000 | EP1017809A2 Human regulatory molecules |
| 07/12/2000 | EP1017808A2 53bp2 complexes |
| 07/12/2000 | EP1017807A1 Osf2/cbfa1 compositions and methods of use |
| 07/12/2000 | EP1017806A2 Compositions and methods for conferring tick immunity and preventing tick borne diseases |
| 07/12/2000 | EP1017805A1 $i(MEN1), THE GENE ASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 1, MENIN POLYPEPTIDES, AND USES THEREOF |
| 07/12/2000 | EP1017802A1 A potential effector for the grb7 family of signalling proteins |
| 07/12/2000 | EP1017725A1 Method of affinity cross-linking biologically active, immunogenic peptides to antibodies |
| 07/12/2000 | EP1017723A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 07/12/2000 | EP1017720A1 Site-directed chemotherapy of metastases |
| 07/12/2000 | EP1017714A1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) |
| 07/12/2000 | EP1017712A1 Ucp3 genes |
| 07/12/2000 | EP1017707A1 29 human secreted proteins |
| 07/12/2000 | EP1017704A2 Use of a pentopyranosyl nucleoside for producing an electronic component, and conjugates of said pentopyranosyl nucleoside |
| 07/12/2000 | EP1017703A2 Pentopyranosyl nucleoside, and production and use of the same |
| 07/12/2000 | EP1017412A1 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease |
| 07/12/2000 | EP1017407A2 Useful properties of human lactoferrin and variants thereof |
| 07/12/2000 | EP1017373A2 REGULATION OF CELLULAR APOPTOSIS USING MODULATORS OF $g(b)-AR RECEPTORS |
| 07/12/2000 | EP0680336B1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants |
| 07/12/2000 | EP0673390B1 Delta-like gene expressed in neuroendocrine tumors |
| 07/12/2000 | EP0580596B1 Gene mutated in colorectal cancer of humans |
| 07/12/2000 | EP0413762B1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 07/12/2000 | CN1260000A Recombination proteins of Pakistani strain of hepatitis E and their use in diagnostic method and vaccines |
| 07/12/2000 | CN1259962A Anti-vegf antibodies |
| 07/12/2000 | CN1259961A Humanized antibodies and method for forming same |
| 07/12/2000 | CN1259574A New human phosphatide transferase, its code sequence, prepn. and use thereof |
| 07/12/2000 | CN1259573A New human serine threonine protein kinase, its code sequence, prepn. and use thereof |
| 07/12/2000 | CN1259572A New human protein and its code sequence, prepn. method and use thereof |
| 07/12/2000 | CN1259524A Method for induction and prepn. of epitope idiosyncratic monoclonal antibody by using epitope polypeptide |
| 07/12/2000 | CN1259522A Novel protain from lobar pneumonia Actinomyces |
| 07/11/2000 | US6087477 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 07/11/2000 | US6087476 Photoprotein like aequorin, obelin, berovin, or mnemiopsin linked to antigen-specific protein like light-chain or heavy-chain immunoglobulin, avidin, strepavidin, protein a, or an antigenic peptide or fragment; sensitive immunoassay |
| 07/11/2000 | US6087475 PF4A receptor |
| 07/11/2000 | US6087375 Methods of treating or preventing thromboses |
| 07/11/2000 | US6087331 Therapeutic use of platelet-endothelial cell adhesion molecule-1 compositions |
| 07/11/2000 | US6087169 HKABY60: polynucleotide encoding a helix-loop-helix ubiquitous kinase family polypeptide |
| 07/11/2000 | US6087150 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |